Characterization of a MOSkin detector for in vivo skin dose measurements during interventional radiology procedures M. J. Safari, J. H. D. Wong, K. H. Ng, W. L. Jong, D. L. Cutajar, and A. B. Rosenfeld Citation: Medical Physics 42, 2550 (2015); doi: 10.1118/1.4918576 View online: http://dx.doi.org/10.1118/1.4918576 View Table of Contents: http://scitation.aip.org/content/aapm/journal/medphys/42/5?ver=pdfcov Published by the American Association of Physicists in Medicine Articles you may be interested in Characterizing energy dependence and count rate performance of a dual scintillator fiber-optic detector for computed tomography Med. Phys. 42, 1268 (2015); 10.1118/1.4906206 Comparison of measured and estimated maximum skin doses during CT fluoroscopy lung biopsies Med. Phys. 41, 073901 (2014); 10.1118/1.4884231 Characterization of a cable-free system based on p-type MOSFET detectors for “in vivo” entrance skin dose measurements in interventional radiology Med. Phys. 39, 4866 (2012); 10.1118/1.4736806 Dosimetric evaluation of the OneDose™ MOSFET for measuring kilovoltage imaging dose from image-guided radiotherapy procedures Med. Phys. 37, 4880 (2010); 10.1118/1.3483099 A new approach in dose measurement and error analysis for narrow photon beams (beamlets) shaped by different multileaf collimators using a small detector Med. Phys. 31, 2020 (2004); 10.1118/1.1760191 Characterization of a MOSkin detector for in vivo skin dose measurements during interventional radiology procedures M. J. Safari, J. H. D. Wong, and K. H. Nga) Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia and University of Malaya Research Imaging Centre, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia W. L. Jong Clinical Oncology Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia D. L. Cutajar and A. B. Rosenfeld Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW 2522, Australia (Received 3 September 2014; revised 20 March 2015; accepted for publication 4 April 2015; published 23 April 2015) Purpose: The MOSkin is a MOSFET detector designed especially for skin dose measurements. This detector has been characterized for various factors affecting its response for megavoltage photon beams and has been used for patient dose measurements during radiotherapy procedures. However, the characteristics of this detector in kilovoltage photon beams and low dose ranges have not been studied. The purpose of this study was to characterize the MOSkin detector to determine its suitability for in vivo entrance skin dose measurements during interventional radiology procedures. Methods: The calibration and reproducibility of the MOSkin detector and its dependency on different radiation beam qualities were carried out using RQR standard radiation qualities in free-in-air geometry. Studies of the other characterization parameters, such as the dose linearity and dependency on exposure angle, field size, frame rate, depth-dose, and source-to-surface distance (SSD), were carried out using a solid water phantom under a clinical x-ray unit. Results: The MOSkin detector showed good reproducibility (94%) and dose linearity (99%) for the dose range of 2 to 213 cGy. The sensitivity did not significantly change with the variation of SSD (±1%), field size (±1%), frame rate (±3%), or beam energy (±5%). The detector angular dependence was within ±5% over 360◦ and the dose recorded by the MOSkin detector in different depths of a solid water phantom was in good agreement with the Markus parallel plate ionization chamber to within ±3%. Conclusions: The MOSkin detector proved to be reliable when exposed to different field sizes, SSDs, depths in solid water, dose rates, frame rates, and radiation incident angles within a clinical x-ray beam. The MOSkin detector with water equivalent depth equal to 0.07 mm is a suitable detector for in vivo skin dosimetry during interventional radiology procedures. C 2015 American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4918576] Key words: MOSFET detector, MOSkin, skin dose monitoring, skin dosimetry, interventional radiology, in vivo dosimetry 1. INTRODUCTION According to the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) report, 3.6 × 109 diagnostic radiology x-ray examinations are performed worldwide annually, with this number increasing every year.1 Until the late 1980s, diagnostic procedures were characterized as low dose radiation procedures and were only linked with stochastic risks. Since the 1980s, fluoroscopically guided interventional procedures have become widespread and have been used effectively to diagnose and treat numerous vascular and cardiac diseases. Although interventional procedures provide enormous advantages over invasive surgical procedures, long periods of radiation exposure may increase the risk of deterministic effects in patients, thus causing radiation-induced skin injuries.2–7 2550 Med. Phys. 42 (5), May 2015 The US Food and Drug Administration (FDA),8 the World Health Organization (WHO),9 the International Commission on Radiological Protection (ICRP),10 and the International Atomic Energy Agency (IAEA)11 have all expressed concerns regarding patient skin dose. They have also issued guidance on the prevention of skin injuries in high dose interventional procedures. In order to prevent severe radiation injuries, it is important to evaluate the entrance skin dose (ESD) of patients during long irradiation periods. To address these issues, several radiation dose tracking systems have been developed and are available for purchase. The Patient Exposure Monitoring Network (PEMNET®) System (Clinical Microsystems, Inc., Arlington, VA) was designed to calculate and display the realtime exposure rate and subsequently the patient’s ESD based on the exposure parameters and the patient geometry information.12 The PEMNET®, however, does not differentiate the 0094-2405/2015/42(5)/2550/10/$30.00 © 2015 Am. Assoc. Phys. Med. 2550 2551 Safari et al.: Calibration of MOSkin for skin dose measurement 2551 F. 1. Schematic of (a) MOSkin dosimetry system, (b) MOSFET detector with an epoxy bubble encapsulation above the sensitive area, (c) MOSkin detector face-up orientation, and (d) MOSkin detector face-down orientation. radiation locations on the patient’s skin and cannot provide the spatial dose distribution information required to calculate the ESD. Various indirect beam-monitoring quantities have been used to estimate the ESD in fluoroscopically guided procedures, such as the kerma-area-product (KAP), fluoroscopy time, number of images, and dose level at the interventional reference point (IRP).13,14 Although these quantities are widely used as an indicator for the entrance skin dose, several studies have shown that they provide an unrealistic estimation of the ESD in interventional radiology procedures.13–16 Recently, several skin dose estimation tools have been developed using exposure parameters (exposure rate, kVp, mAs, exposure angle, table height, etc.). This information is extracted from DICOM tags and registered to standard and anatomical patient model phantoms.17,18 These systems estimate the skin dose during IR procedures by taking into account various parameters, such as the dose level at IRP, corrected source skin distance, backscatter factor, and correction of mass energy absorption coefficients of skin to air. The limitations of these systems are that they have been implemented by a limited number of manufacturers (e.g., Toshiba Dose Tracking System) and are not commercially available in all fluoroscopy machines. The anatomical model phantoms do not represent the exact physical shape of the patients and mispositioning of the patient can be an issue when considering the dose evaluation uncertainty. The evaluation of the dose absorbed by the skin of patients can be achieved by means of a direct dosimetry method. Currently, different direct dosimetry methods have been used to measure skin dose during interventional radiology proceMedical Physics, Vol. 42, No. 5, May 2015 dures: thermoluminescent dosimeters (TLDs),15,19 radiochromic films,15,20–22 glass dosimeters,23–25 MOSFET radiation sensors,26–28 and scintillator dosimeters.29 The desirable properties of a detector for monitoring ESD during interventional procedure include small physical size to preserve the image quality, ability to track the dose every second, linear response within the measured dose range, ease of usage, and an appropriate water equivalent depth (WED) for monitoring the skin dose. According to the ICRP Report 59, for accurate skin dose measurements, the WED value associated with the detector should be equal to 0.07 mm.30 This depth is approximately equal to the average depth of the basal layer of the epidermis that comprises the most radiosensitive epithelial cells. The MOSkin detector is a new type of MOSFET detector developed and prototyped by the Centre for Medical Radiation Physics (CMRP), University of Wollongong, Australia [Fig. 1(a)]. The MOSkin detector was designed especially for skin dose measurements.31 This detector has previously been tested and found to be suitable for skin dose measurements in radiation therapy.31–33 This research focuses on the characterization of the MOSkin to determine its suitability for use as an in vivo skin dosimeter during interventional radiology procedures. 2. MATERIALS AND METHODS The MOSkin detector was designed using a new packaging structure in which the p-MOSFET sensor with a thick gate oxide is hermetically sealed within a Kapton pigtail strip using “drop-in” packaging technology [Fig. 1(a)]. A thin polyamide 2552 Safari et al.: Calibration of MOSkin for skin dose measurement 2552 T I. RQR standard radiation qualities. Radiation beam quality RQR3 RQR4 RQR5 RQR6 RQR7 RQR8 RQR9 a Tube potential (kVp) Effective energy (keV)a Added filtration (mm Al) Half value layer (mm Al) 50 60 70 80 90 100 120 27.04 29.23 31.66 34.02 36.05 38.66 42.76 2.7 2.8 3.1 3.2 3.4 3.7 4.0 1.8 2.1 2.5 3.0 3.4 4.1 5.1 Effective energies were obtained from NIST website (Ref. 37). film layer works as a moisture protector and build-up layer, providing a WED of approximately 0.07 mm in tissue,31,34 as compared to commercial MOSFET detectors, which utilize wire-bonding and an epoxy bubble encapsulation above the sensitive region [Fig. 1(b)]. The principle behind the operation of MOSkin detectors is based on the shift of the threshold voltage due to electron–hole generation within the gate oxide, followed by the capture of holes on border traps. The threshold voltage change, ∆Vth, is proportional to the absorbed dose. The detector sensitivity is defined as Sensitivity = ∆Vth (mV) . Dose (cGy) (1) The MOSkin detector has a finite lifetime due to the accumulation of radiation dose, which saturates the hole-traps near the Si–SiO2 interface. The lifetime threshold voltage was reported to be approximately 24 V, determined using the CMRP designed electrometer rather than the MOSkin detectors themselves.35 In this research, the MOSkin detector response in terms of energy, field size, exposure angle, sourceto-surface distance (SSD), and dose rate and percent depthdose (PDD) dependences under various diagnostic beam qualities was investigated. The MOSkin detector calibration and dependence on radiation energy were carried out using the standard radiation quality (RQR: radiation qualities in radiation beams emerging from the x-ray tube assembly) according to IEC 61267 (Ref. 36) in free air geometry. The free-in-air geometry was achieved by placing the detectors on an elevated platform made of styrofoam. The radiation beams were generated by a Y-TU 160D02 x-ray machine (COMET AG, Flammat, Switzerland), at the Secondary Standard Dosimetry Laboratory (SSDL) of the Malaysian Nuclear Agency. Table I shows the parameters of the various RQR standard qualities. The MOSkin detector linearity and reproducibility, angular dependence, field size dependence, PDD in solid water, dose rate dependence, frame rate dependence, and source-to-surface distance dependence were studied using a clinical C-arm fluoroscopy unit (Philips Allura Xper FD20/20® x-ray unit, Philips Healthcare, Amsterdam, Netherlands) at the University of Malaya Medical Centre (UMMC). Characterization procedures were carried out using a 30×30×12 cm3 water equivalent plastic phantom (Gammex 457, Gammex, Middleton, WI) and the x-ray tube was positioned at a gantry angle of 180◦, perpendicular to the phantom surface [Fig. 2(a)]. The detector was characterized for an 80 kVp photon beam (effective energy 42.7 keV) using nonmag- F. 2. Characterization setups with C-arm x-ray tube fluoroscopy unit, (a) standard setup and (b) measurement setup for angular dependency test. Medical Physics, Vol. 42, No. 5, May 2015 2553 Safari et al.: Calibration of MOSkin for skin dose measurement 2553 nified acquisition mode imaging (field of view: 48 cm), while the exposure frame rate was fixed to 3 frames/s. The flat panel detector was placed 120 cm from the x-ray tube focal spot and a field size of 10 × 10 cm2 was used. This setup is henceforth called the “standard setup” [Fig. 2(a)]. The MOSkin detector was placed facing the x-ray tube unless otherwise stated. The characterization procedures under RQR standard radiation qualities were benchmarked against a 30 cm3 parallel plate ionization chamber (model 233612, PTW, Freiburg, Germany), while measurements under the Philips Allura Xper FD20/20® unit were benchmarked against a 0.055 cm3 Markus parallel plate ion chamber (model 23343, PTW, Freiburg, Germany). All measurements were repeated three times and the standard deviation (1 SD) of the results was reported. Two types of uncertainties were considered in the analysis of the MOSkin characteristics. The MOSkin reader shows the threshold voltage change with an uncertainty of 1 mV, and the immediate readout of the detector after irradiation can generate voltage creep-up, up to 4 mV.31 The creep-up voltage depends on the time between successive readouts, which peaks 10 s following the end of irradiation. This component of uncertainty can be reduced with a one-minute post-irradiation wait time.38 The significance of these uncertainties is dependent on the total dose delivery to the MOSkin detector, and it is negligible during high dose delivery when the change in threshold voltage is large. In this research, the dose delivered to the detector was in the lower range; therefore, these uncertainties were taken into account in the results. Furthermore, a oneminute postirradiation wait time was used before readout. A study on temperature dependence of the MOSFET detector reported a threshold voltage variation of 50 mV for a temperature change from 20 to 40 ◦C (Ref. 39) for the used readout current. To avoid a temperature effect on MOSkin detector reading, the MOSkin detector was placed on the styrofoam or solid water phantom, inside the measurement room, for approximately 5 min before starting the measurement to allow for temperature equalization. The ambient temperature was continuously monitored throughout the experimental procedures. Automatic brightness control (ABC) was used to control the x-ray tube output. ABC controls the light output of the image receptor by adjusting the kVp and/or mA of the x-ray tube using a preprogrammed kVp-mA curve.40 The small size and design of the MOSkin detector do not change the ABC exposure parameters when it is in the beam. In this study, the MOSkin detector was set up, per the standard setup, and the sensitivity of the MOSkin detector was studied for the dose range of 2 to 213 cGy. The MOSkin’s response was benchmarked against the Markus chamber. Any deviation in exposure time and/or mAs was corrected based on the exposure parameters recorded from the console (mAs, number of images, KAP). The reproducibility of the MOSkin detector was assessed based on the mean of the standard deviations for three sets of measurements. 2.A. Calibration 2.E. Depth-dose measurements The MOSkin detector was calibrated under RQR7 beam quality (effective energy 36.1 keV) and the exposure fixed at 140 mAs. The detector was placed on a styrofoam board at a SSD of 100 cm and field size of 13 cm diameter. The PTW ion chamber measurements for comparison were corrected for temperature, pressure, and energy, while the reproducibility of the PTW ion chamber was measured to be better than 99%. MOSkin and Markus detectors were initially set up, per the standard setup, followed by placement at different depths in a solid water phantom. For all depth-dose measurements, the detectors were placed along the beam central axis separately to minimize the uncertainty caused by the detector positioning. Depth-dose measurements were tested for 0–35 mm depths from the surface of the solid water phantom. 2.B. Energy dependence measurements Semiconductor detectors are known to be energy-dependent, particularly in the kV beam energy range. The high atomic number (Z) of the detector sensitive volume (silicon oxide, Z = 14) is expected to over-respond at low kV energies due to the photoelectric absorption effect. This study Medical Physics, Vol. 42, No. 5, May 2015 was carried out to investigate the magnitude of the energy dependence of the MOSkin detector for the beam energy range commonly used in diagnostic radiological procedures. The MOSkin energy dependence was studied for the beam energy range of RQR3 to RQR9 (effective energy 27.04–42.76 keV). The exposure was fixed at 140 mA s. The MOSkin detector was placed at a SSD of 100 cm and a field size of 13 cm diameter was used. 2.C. Dose linearity and reproducibility measurements 2.D. Field size dependence measurements Field size dependence is an important factor for point dose recording during interventional radiology procedures since multiple field sizes are often used within a treatment procedure. The ABC system adjusts the tube output to maintain the image brightness at a constant level for different exposure field sizes. As the exposure field size decreases, the tube current increases, and subsequently, the exposure dose increases. The MOSkin was set up, per the standard setup, at a SSD of 70 cm with selected field sizes from 5 × 5 cm to 20 × 20 cm. 2.F. Source-to-surface distance dependence The MOSkin detector was set up, per the standard setup, and placed at a SSD of 90 cm with an exposure field size of 10 × 10 cm, with the SSD adjusted by moving the couch toward the x-ray tube. The detector response at different distances (70–90 cm) was studied. The MOSkin detector dose rate dependence was also evaluated using this setup. 2554 Safari et al.: Calibration of MOSkin for skin dose measurement 2554 F. 3. Energy dependence of the MOSkin detector for diagnostic energy range, under RQR standard beam qualities. The values were normalized to 1 at 36.1 keV and the average standard deviation of three measurements is presented. 2.G. Frame rate dependence The Philips Allura Xper FD20/20® system classifies the frame rate for angiography procedures into two main categories, i.e., cardiac and vascular applications. The vascular application allows operators to select acquisition exposures with frame rates of 2, 3, 4, and 6 frames/s while the frame rates of 15 and 30 frames/s are for cardiac applications. In this study, the MOSkin detector was set up, per the standard setup, and both application types were used to study the dependence of the MOSkin detector to the exposure frame rate. The exposure parameters were recorded from the console (kV, mA, ms, and filter). The effective energies (keV) were calculated based on measured HVLs using an Unfors detector (Unfors Raysafe AB, Billdal, Sweden). 2.H. Angular dependence measurements The C-arm x-ray tube can rotate from 120◦ left anterior oblique (LAO) to 180◦ right anterior oblique (RAO) and hence, cannot cover the entire angular range. Due to this limitation, the solid water phantom was placed at the edge of the patient support couch [Fig. 2(b)] at a SSD of 81 cm (isocenter of rotation). The MOSkin detector was placed in the center of the surface of the solid water phantom on the central axis. The C-arm x-ray tube was rotated from 30◦ RAO to 150◦ RAO in 20◦ intervals, and the angular response of the MOSkin detector was assessed for face-up and face-down orientations [Figs. 1(c) and 1(d)]. Other exposure parameters followed the standard setup. 3. RESULTS AND DISCUSSION 3.A. Detector calibration The sensitivity of the MOSkin detector for a RQR7 beam quality (effective energy 36.1 keV) photon beam was measured to be 11.56 ± 0.36 mV cGy−1. Previous research reported that the sensitivity of the MOSkin detector for 150 kVp xray beam (effective energy 64.87 keV) was approximately 6.70 mV cGy−1, which was measured in comparison with EBT2 film.41 The sensitivity of the MOSkin detector in a megavoltage beam was 2.63 ± 0.01 mV cGy−1.42 The higher sensitivity measured at lower beam energy is due to the increasing dominance of photoelectric absorption and consequently, an F. 4. Linearity of the MOSkin detector benchmarked against the Markus ion chamber. Average standard deviation of this measurement was ±2 mV. Medical Physics, Vol. 42, No. 5, May 2015 2555 Safari et al.: Calibration of MOSkin for skin dose measurement 2555 F. 5. The field size effects on response for the MOSkin detector. All the readings were normalized to a field size of 10 × 10 cm. increasing response of the MOSkin detector at low energy. The MOSkin detector sensitivity decreases as the cumulative dose increases. Our recent study showed that the MOSkin detector’s sensitivity decreased by 0.09 mV/cGy with every increase of 10 Gy accumulated dose in megavoltage radiation, which is equivalent to sensitivity reduction of 1.5%/V increase in the threshold voltage.43 Hence, it is recommended to recalibrate the detector periodically over its useful lifetime based on the accuracy needed. The lifetime of a MOSkin detector is determined by the initial voltage (∼10 V), the sensitivity of detector, and the maximum threshold voltage (∼24 V). When used under diagnostic beam energies, the detector lifetime is approximately equivalent to 12 Gy of radiation exposure. 3.B. Energy dependence Figure 3 shows the MOSkin detector’s response, normalized to RQR7 beam quality. As expected, the MOSkin detector showed enhanced response at lower beam energies. The detector over-responded by a factor of 1.15 at 50 kVp (effective beam energy 27.04 keV). At 120 kVp (effective beam energy 42.76 keV), the detector under-responded by a factor of 0.86. However, for the tube potentials that are commonly used in interventional radiology procedures (70–100 kVp), the detector response varies within ±5%. The ratio of massenergy absorption coefficient of silicon (Si) to air was defined as Ratio of mass-energy absorption coefficient = (2) where (µen/ρ)Si and (µen/ρ)air are mass-energy absorption coefficients of Si and air, respectively. The measured ratio was normalized to 1 at 36.1 keV. As Fig. 3 illustrates, the change of the MOSkin detector’s sensitivity for different effective beam energies shows the same tendency with the ratio of the massenergy absorption coefficient of Si to air. This comparison does not take into account the change of recombination of electron-hole pairs in the gate of the MOSFET with decreasing photon energy.44 The ratio of the mass-energy absorption coefficients of Si to air has the same trend as the ratio of Si to water. F. 6. Depth dose in solid water for FSD of 10 × 10 cm. All the readings are normalized to the surface dose (100%). Medical Physics, Vol. 42, No. 5, May 2015 (µen/ρ)Si , (µen/ρ)air 2556 Safari et al.: Calibration of MOSkin for skin dose measurement 2556 F. 7. Source-to-surface distance and dose rate dependence of the MOSkin detector for an 80 kVp x-ray beam with an exposure field size of 10 × 10 cm. 3.C. Dose linearity and reproducibility The MOSkin detector showed a linear response with the amount of delivered dose (2–213 cGy) measured by Markus ion chamber to be better than 0.99 (Fig. 4). The reproducibility of the MOSkin measurements was found to be better than 94%. 3.D. Field size dependence The ABC controlled the brightness of the image for different exposure field sizes by adapting the milliampere-second. A smaller exposure field size had a higher beam exposure (mAs). For this study, the tube potential remained constant throughout the measurements at 80 kVp (effective beam energy 42.76 keV), and the beam exposure changed from 61 to 8 mAs for 5 × 5 cm to 20 × 20 cm exposure field sizes, respectively. Figure 5 illustrates that the MOSkin detector is independent of field size variation (within ±1%). 3.E. Depth-dose data The percentage depth-dose response of the MOSkin detector was investigated previously,41,45 which compared the MOSkin detector response with Markus chamber and Monte Carlo simulations in water. In their reports, the MOSkin detector showed an over-response compared with the Markus chamber measurements,41 while Monte Carlo simulations showed MOSkin to have good agreement with simulated water response (±3%).45 In this study, Fig. 6 shows the percentage depth-dose curves for the MOSkin and Markus ion chamber. Both detector responses were normalized to their response at the surface of the solid water phantom. The MOSkin detector appears to be in good agreement with the Markus chamber to within ±3%. The largest deviation between the MOSkin and Markus detectors’ response was 4% at 2 mm. These data are in good agreement with the Monte Carlo simulations for the 100 kVp beam (effective photon energy of 48.6 keV).45 The MOSkin detector for this study was calibrated and measured for the effective photon energy of 42.76 keV. 3.F. Source-to-surface distance dependence Figure 7 shows the dose measured by the MOSkin and the Markus chamber corrected for inverse square law. The MOSkin showed good agreement with the Markus chamber measurements (±1%). The error bars increased with greater distance due to the lower dose delivered to the detector. Consequently, the effects of reader and voltage creep uncertainties become noticeable. The SSD parameter is an important feature T II. Effective energy and dose rate values for different frame rates of cardiac and vascular applications, controlled by AEC system. Application types Vascular Cardiac a Frame rate (frames/s) Tube potential (kVp) Added filtration (mm) HVL (mm Al) Effective energy (keV)a Dose rate (mGy/s) 2 3 4 6 15 30 83.50 83.48 83.45 78.64 70.84 70.93 0.1 Cu + 1.0 Al 0.1 Cu + 1.0 Al 0.1 Cu + 1.0 Al 0 0 0 5.07 5.09 5.07 3.22 2.57 2.58 42.54 42.61 42.54 34.84 31.55 31.60 1.68 1.99 2.53 3.68 0.58 1.19 Effective energies were obtained from NIST website (Ref. 37). Medical Physics, Vol. 42, No. 5, May 2015 2557 Safari et al.: Calibration of MOSkin for skin dose measurement 2557 F. 8. MOSkin detector frame rate and dose rate dependences of vascular and cardiac applications. for interventional radiology dosimetry, as the x-ray tube is continuously rotated around the patient during interventional radiology procedures. Depending on the location of the patient’s body, the x-ray tube is placed at different distances from the body surface. The FDA has expressed concerns about SSD in fluoroscopic procedures and has suggested using a SSD of 38 cm as a threshold for stationary fluoroscopy units and 30 cm for mobile fluoroscopy units.46 Figure 7 also shows the relative response of the MOSkin and Markus detectors, normalized to their ratio at 1.2 mGy/s dose rate. MOSkin detector shows a very low dependence on exposure dose rate (<1%). 3.G. Frame rate dependence Table II shows the different frame rates available on the Philips Allura Xper FD20/20® system, grouped under cardiac and vascular applications. Note that when switching from the high frame rates to the low frame rates, the system automatically adjusted the tube potential (filtration) and dose rate. Figure 8 shows that MOSkin detector has low dependence on frame rate and dose rate variations (coefficient of variation = ±3%). This variation is within the uncertainty due to the energy dependence of MOSkin detector. 3.H. Angular dependence The angular dependence of the MOSkin detector is presented in Fig. 9. The variation in the readings for the azimuth axis was within ±5%. The lowest drop in sensitivity occurred at −60◦ face-up and the maximum sensitivity was obtained at 0◦ face-down. The MOSkin detector has a different WED for face-down and face-up orientations (inherent anisotropy) on the surface of the phantom. This detector has a thicker build-up layer due to the silicon substrate in the case of facedown orientation [Figs. 1(c) and 1(d)], which produces more secondary electrons and subsequently causes dose enhancement at the sensitive volume of the MOSkin. On the other hand, photon attenuation in the silicon substrate exists as well, with the response of the device affected by a combination of the two processes. The MOSkin detector shows slightly higher sensitivity in a face-down orientation relative to a face-up orientation. As Fig. 9 shows, the MOSkin detector’s sensitivity F. 9. The azimuth angular dependence of the MOSkin detector. The MOSkin response was normalized to the 0◦ value in face-up orientation. Medical Physics, Vol. 42, No. 5, May 2015 2558 Safari et al.: Calibration of MOSkin for skin dose measurement decreases with increasing exposure angle. This change in the MOSkin detector sensitivity is due to the intrinsic angular dependence of MOSkin and the effect of backscatter radiation. Published reports on the angular dependence of the MOSkin detector for a 6 MV x-ray field reported that this detector has a very low intrinsic dependence on exposure angle31,47 and the minimum angular dependence for this detector was measured for a dual MOSkin to within ±2.5% around the azimuth axis under charged particle equilibrium conditions.42 For kilovoltage x-rays, the field contribution of the intrinsic response to the skin dose measurements with a single face on MOSkin is slightly larger in comparison to a dual MOSkin in a 6 MV field but is still small enough for this application. and N. Abdullah at the Medical Physics group of Malaysian Nuclear Agency, Dr. N. M. Ung at the Clinical Oncology Unit, University of Malaya, C. C. Lee and M. Mozaker, radiographers at the UMMC, and K. H. Lam at Philips Healthcare Malaysia and Medical Physics Unit (UMMC) for the loan of equipment for this research. The authors would like to thank the reviewers, editor, and associate editor for their time and effort in improving this manuscript. This study was supported by the High Impact Research (HIR) grant, UM.C/625/1/HIR/MOHE/MED/38, Account No. H-2000100-E000077, and PPP grant, PG035- 2013A from the University of Malaya. a)Author 4. CONCLUSION In this study, the MOSkin detector was characterized for its diagnostic beam energies. The dose linearity, reproducibility, and depth-dose measurements were performed. The detector’s response with variations of beam energy, field size, sourcesurface distance, frame rate, and beam incidence angles was also investigated. This work demonstrated that the MOSkin detector is suitable for monitoring the skin dose during interventional radiology procedures, taking into account the various uncertainties and limitations of the detector. The limitation of this system is that the MOSkin as a point dosimetry system may not be placed at the location where the skin experiences the most intense radiation dose. Hence, there may be an underestimation of the MSD during IR procedures. For this purpose, a 2D dosimeter, such as film, would still provide the best solution. Nevertheless, using multiple MOSkin detectors simultaneously to measure dose at selected regions of interest or radiosensitive organs, such as the eye lens, would still be useful in providing insights into the radiation dose received by these organs. Compared to other commercially available dose tracking systems, which predict the 2D dose distribution for patients via parameters from the fluoroscopic machine, this system does not provide 2D dose distribution information. Nevertheless, this system tracks the dose every second using actual direct skin dose measurements. Similar to other dose tracking systems, this system also enables interventional radiologists to balance the expected clinical benefits and radiation risks of performing a procedure. Skin dose is an important issue for patient radiation safety during interventional radiology procedures. The MOSkin detector, with WED equal to 0.07 mm, is a suitable detector for in vivo skin dose measurements. Future work would include the application of this detector system in clinical interventional radiological procedures. This detector can be used as an eye lens dose tracking system during neuro-interventional procedures without interfering with the treatment procedure, due to the small physical size and transparency on the patient’s image. ACKNOWLEDGMENTS The authors acknowledge and thank the personnel at the following institutions for their support in this study: M. J. Isa Medical Physics, Vol. 42, No. 5, May 2015 2558 to whom correspondence should be addressed. Electronic mail: ngkh@um.edu.my 1United Nations Scientific Committee on the Effects of Atomic Radiation, UNSCEAR 2008 Report to the General Assembly (United Nations, New York, NY, 2010). 2T. B. Shope, “Radiation-induced skin injuries from fluoroscopy,” Radiographics 16(5), 1195–1199 (1996). 3E. Vano, L. Arranz, J. M. Sastre, C. Moro, A. Ledo, M. T. Garate, and I. Minguez, “Dosimetric and radiation protection considerations based on some cases of patient skin injuries in interventional cardiology,” Br. J. Radiol. 71(845), 510–516 (1998). 4L. K. Wagner, M. D. McNeese, M. V. Marx, and E. L. Siegel, “Severe skin reactions from interventional fluoroscopy: Case report and review of the literature,” Radiology 213(3), 773–776 (1999). 5T. H. Frazier, J. B. Richardson, V. C. Fabre, and J. P. Callen, “Fluoroscopyinduced chronic radiation skin injury: A disease perhaps often overlooked,” Arch. Dermatol. 143(5), 637–640 (2007). 6S. Balter, J. W. Hopewell, D. L. Miller, L. K. Wagner, and M. J. Zelefsky, “Fluoroscopically guided interventional procedures: A review of radiation effects on patients’ skin and hair,” Radiology 254(2), 326–341 (2010). 7A. Spiker, Z. Zinn, W. H. Carter, R. Powers, and R. Kovach, “Fluoroscopyinduced chronic radiation dermatitis,” Am. J. Cardiol. 110(12), 1861–1863 (2012). 8Food and Drug Administration, Public Health Advisory: Avoidance of Serious X-ray-Induced Skin Injuries to Patients During FluoroscopicallyGuided Procedures (Center for Devices and Radiological Health, Rockville, MD, 1994). 9World Health Organization and Institut für Strahlenhygiene des Bundesgesundheitsamtes, Efficacy and Radiation Safety in Interventional Radiology (World Health Organization, Switzerland, Geneva, 2000). 10J. Valentin, “Avoidance of radiation injuries from medical interventional procedures,” Ann. ICRP 30(2), 7–67 (2000). 11International Atomic Energy Agency, “Patient dose optimization in fluoroscopically guided interventional procedures,” IAEA-TECDOC-1641: IAEA (2010). 12J. T. Cusma, M. R. Bell, M. A. Wondrow, J. P. Taubel, and D. R. Holmes, Jr., “Real-time measurement of radiation exposure to patients during diagnostic coronary angiography and percutaneous interventional procedures,” J. Am. Coll. Cardiol. 33(2), 427–435 (1999). 13J. W. Jaco and D. L. Miller, “Measuring and monitoring radiation dose during fluoroscopically guided procedures,” Tech. Vasc. Interv. Radiol. 13(3), 188–193 (2010). 14S. Balter, D. W. Fletcher, H. M. Kuan, D. Miller, D. Richter, H. Seissl, and T. B. Shope, “Techniques to estimate radiation dose to skin during fluoroscopically guided procedures,” AAPM Summer School Proceedings, Madison, WI (2002). 15E. Vano, L. Gonzalez, J. I. Ten, J. M. Fernandez, E. Guibelalde, and C. Macaya, “Skin dose and dose-area product values for interventional cardiology procedures,” Br. J. Radiol. 74(877), 48–55 (2001). 16S. Balter, “Methods for measuring fluoroscopic skin dose,” Pediatr. Radiol. 36(Suppl. 2), 136–140 (2006). 17P. B. Johnson, D. Borrego, S. Balter, K. Johnson, D. Siragusa, and W. E. Bolch, “Skin dose mapping for fluoroscopically guided interventions,” Med. Phys. 38(10), 5490–5499 (2011). 18Y. Khodadadegan, M. Zhang, W. Pavlicek, R. G. Paden, B. Chong, B. A. Schueler, K. A. Fetterly, S. G. Langer, and T. Wu, “Automatic monitoring 2559 Safari et al.: Calibration of MOSkin for skin dose measurement of localized skin dose with fluoroscopic and interventional procedures,” J. Digital Imaging 24(4), 626–639 (2011). 19S. L. Dong, T. C. Chu, G. Y. Lan, T. H. Wu, Y. C. Lin, and J. S. Lee, “Characterization of high-sensitivity metal oxide semiconductor field effect transistor dosimeters system and LiF: Mg,Cu, P thermoluminescence dosimeters for use in diagnostic radiology,” Appl. Radiat. Isot. 57(6), 883–891 (2002). 20S. Delle Canne, A. Carosi, A. Bufacchi, T. Malatesta, R. Capperella, R. Fragomeni, N. Adorante, S. Bianchi, and L. Begnozzi, “Use of GAFCHROMIC XR type R films for skin-dose measurements in interventional radiology: Validation of a dosimetric procedure on a sample of patients undergone interventional cardiology,” Phys. Med. 22(3), 105–110 (2006). 21L. D’Ercole, L. Mantovani, F. Z. Thyrion, M. Bocchiola, A. Azzaretti, F. Di Maria, C. M. Saluzzo, P. Quaretti, G. Rodolico, P. Scagnelli, and L. Andreucci, “A study on maximum skin dose in cerebral embolization procedures,” AJNR, Am. J. Neuroradiol. 28(3), 503–507 (2007). 22B. A. Schueler, D. F. Kallmes, and H. J. Cloft, “3D cerebral angiography: Radiation dose comparison with digital subtraction angiography,” AJNR, Am. J. Neuroradiol. 26(8), 1898–1901 (2005). 23T. Moritake, Y. Matsumaru, T. Takigawa, K. Nishizawa, A. Matsumura, and K. Tsuboi, “Dose measurement on both patients and operators during neurointerventional procedures using photoluminescence glass dosimeters,” AJNR, Am. J. Neuroradiol. 29(10), 1910–1917 (2008). 24M. Hayakawa, T. Moritake, F. Kataoka, T. Takigawa, Y. Koguchi, Y. Miyamoto, K. Akahane, and Y. Matsumaru, “Direct measurement of patient’s entrance skin dose during neurointerventional procedure to avoid further radiation-induced skin injuries,” Clin. Neurol. Neurosurg. 112(6), 530–536 (2010). 25T. Moritake, M. Hayakawa, Y. Matsumaru, T. Takigawa, Y. Koguchi, Y. Miyamoto, Y. Mizuno, K. Chida, K. Akahane, and K. Tsuboi, “Precise mapping system of entrance skin dose during endovascular embolization for cerebral aneurysm,” Radiat. Meas. 46(12), 2103–2106 (2011). 26D. J. Peet and M. D. Pryor, “Evaluation of a MOSFET radiation sensor for the measurement of entrance surface dose in diagnostic radiology,” Br. J. Radiol. 72(858), 562–568 (1999). 27D. Glennie, B. L. Connolly, and C. Gordon, “Entrance skin dose measured with MOSFETs in children undergoing interventional radiology procedures,” Pediatr. Radiol. 38(11), 1180–1187 (2008). 28D. D’Alessio, C. Giliberti, A. Soriani, L. Carpanese, G. Pizzi, G. Vallati, and L. Strigari, “Dose evaluation for skin and organ in hepatocellular carcinoma during angiographic procedure,” J. Exp. Clin. Cancer Res. 32 (2013). 29L. K. Wagner and J. J. Pollock, “Real-time portal monitoring to estimate dose to skin of patients from high dose fluoroscopy,” Br. J. Radiol. 72(861), 846–855 (1999). 30ICRP, “The biological basis for dose limitation in the skin. A report of a task group of committee 1 of the international commission on radiological protection,” Ann. ICRP 22(2), 1–104 (1991). 31I. S. Kwan, A. B. Rosenfeld, Z. Y. Qi, D. Wilkinson, M. L. Lerch, D. L. Cutajar, M. Safavi-Naeni, M. Butson, J. Bucci, and Y. Chin, “Skin dosimetry with new MOSFET detectors,” Radiat. Meas. 43(2), 929–932 (2008). Medical Physics, Vol. 42, No. 5, May 2015 2559 32H. Alnawaf, M. Butson, and P. K. Yu, “Measurement and effects of MOSKIN detectors on skin dose during high energy radiotherapy treatment,” Australas. Phys. Eng. Sci. Med. 35(3), 321–328 (2012). 33Z. Y. Qi, X. W. Deng, S. M. Huang, L. Zhang, Z. C. He, X. A. Li, I. Kwan, M. Lerch, D. Cutajar, P. Metcalfe, and A. Rosenfeld, “In vivo verification of superficial dose for head and neck treatments using intensity-modulated techniques,” Med. Phys. 36(1), 59–70 (2009). 34I. S. Kwan, D. Wilkinson, D. Cutajar, M. Lerch, A. Rosenfeld, A. Howie, J. Bucci, Y. Chin, and V. L. Perevertaylo, “The effect of rectal heterogeneity on wall dose in high dose rate brachytherapy,” Med. Phys. 36(1), 224–232 (2009). 35Z. Y. Qi, X. W. Deng, S. M. Huang, J. Lu, M. Lerch, D. Cutajar, and A. Rosenfeld, “Verification of the plan dosimetry for high dose rate brachytherapy using metal-oxide-semiconductor field effect transistor detectors,” Med. Phys. 34(6), 2007–2013 (2007). 36International Electrotechnical Commission, “Radiation conditions for use in the determination of characteristics,” IEC 61267 (2005). 37National Institute of Standards and Technology, X-ray form factor, attenuation, and scattering tables, 2010, available at http://physics.nist.gov/ PhysRefData/FFast/html/form.html, accessed on 12 January 2015. 38R. Ramani, S. Russell, and P. O’Brien, “Clinical dosimetry using MOSFETs,” Int. J. Radiat. Oncol., Biol., Phys. 37(4), 959–964 (1997). 39T. Cheung, M. J. Butson, and P. K. Yu, “Effects of temperature variation on MOSFET dosimetry,” Phys. Med. Biol. 49(13), N191–N196 (2004). 40P. P. Dendy and B. Heaton, Physics for Diagnostic Radiology (CRC, Boca Raton, FL, 2011). 41C. Lian, J. Wong, A. Young, D. Cutajar, M. Petasecca, M. Lerch, and A. Rosenfeld, “Measurement of multi-slice computed tomography dose profile with the dose magnifying glass and the MOSkin radiation dosimeter,” Radiat. Meas. 55, 51–55 (2013). 42N. Hardcastle, D. L. Cutajar, P. E. Metcalfe, M. L. Lerch, V. L. Perevertaylo, W. A. Tome, and A. B. Rosenfeld, “In vivo real-time rectal wall dosimetry for prostate radiotherapy,” Phys. Med. Biol. 55(13), 3859–3871 (2010). 43W. L. Jong, J. H. Wong, N. M. Ung, K. H. Ng, G. F. Ho, D. L. Cutajar, and A. B. Rosenfeld, “Characterization of MOSkin detector for in vivo skin dose measurement during megavoltage radiotherapy,” J. Appl. Clin. Med. Phys. 15(5), 120–132 (2014). 44T. Kron, L. Duggan, T. Smith, A. Rosenfeld, M. Butson, G. Kaplan, S. Howlett, and K. Hyodo, “Dose response of various radiation detectors to synchrotron radiation,” Phys. Med. Biol. 43(11), 3235–3259 (1998). 45C. Lian, M. Othman, D. Cutajar, M. Butson, S. Guatelli, and A. Rosenfeld, “Monte Carlo study of the energy response and depth dose water equivalence of the MOSkin radiation dosimeter at clinical kilovoltage photon energies,” Australas. Phys. Eng. Sci. Med. 34(2), 273–279 (2011). 46M. A. S. Sherer, P. J. Visconti, and E. R. Ritenour, Radiation Protection in Medical Radiography (Elsevier Health Sciences, Maryland Heights, MO, 2013). 47Z. Y. Qi, X. W. Deng, S. M. Huang, A. Shiu, M. Lerch, P. Metcalfe, A. Rosenfeld, and T. Kron, “Real-time in vivo dosimetry with MOSFET detectors in serial tomotherapy for head and neck cancer patients,” Int. J. Radiat. Oncol., Biol., Phys. 80(5), 1581–1588 (2011).